Cocaine serves as a peripheral interoceptive conditioned stimulus for central glutamate and dopamine release.
Intravenous injections of cocaine HCl are habit-forming because, among their many actions, they elevate extracellular dopamine levels in the terminal fields of the mesocorticolimbic dopamine system. This action, thought to be very important for cocaine's strong addiction liability, is believed to have very short latency and is assumed to reflect rapid brain entry and pharmacokinetics of the drug. However, while intravenous cocaine HCl has almost immediate effects on behavior and extracellular dopamine levels, recent evidence suggests that its central pharmacological effects are not evident until 10 or more seconds after IV injection. Thus the immediate effects of a given intravenous cocaine injection on extracellular dopamine concentration and behavior appear to occur before there is sufficient time for cocaine to act centrally as a dopamine uptake inhibitor. To explore the contribution of peripheral effects of cocaine to the early activation of the dopamine system, we used brain microdialysis to measure the effects of cocaine methiodide (MI)--a cocaine analogue that does not cross the blood brain barrier--on glutamate (excitatory) input to the dopamine cells. IP injections of cocaine MI were ineffective in cocaine-naïve animals but stimulated ventral tegmental glutamate release in rats previously trained to lever-press for cocaine HCl. This peripherally triggered glutamate input was sufficient to reinstate cocaine-seeking in previously trained animals that had undergone extinction of the habit. These findings offer an explanation for short-latency behavioral responses and immediate dopamine elevations seen following cocaine injections in cocaine-experienced but not cocaine-naïve animals.
Wise
Roy A
RA
Department of Health and Human Services, Behavioral Neuroscience Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland, United States of America. rwise@intra.nida.nih.gov
Wang
Bin
B
You
Zhi-Bing
ZB
D000818:Animals; D003042:Cocaine / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism*; D004343:Drug Implants; D005108:Extinction, Psychological / Q000187:drug effects; D018698:Glutamic Acid / Q000378:metabolism*; D007262:Infusions, Intravenous; D007601:Jugular Veins; D008297:Male; D017551:Microdialysis; D051381:Rats; D020318:Rats, Long-Evans; D012646:Self Administration
D004343:Drug Implants; D018698:Glutamic Acid; D003042:Cocaine; D004298:Dopamine